Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

LifeStance Health Group, Inc. (LFST) had Return on Tangible Equity of 19.32% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$1.42B
Net Income	$9.66M
Cost of Goods Sold	$963.19M
Gross Profit	$461.10M
Operating Expenses	$1.40B
Operating Income	$24.15M
Non-Operating Income/Expense	$-11.79M
Pre-Tax Income	$12.36M
Normalized Pre-Tax Income	$12.36M
Income after Taxes	$9.66M
Income from Continuous Operations	$9.66M
Consolidated Net Income/Loss	$9.66M
Normalized Income after Taxes	$9.66M
EBIT	$24.15M
EBITDA	$79.92M
Weighted-Average Shares Outstanding (Basic)	386.02M
Weighted-Average Shares Outstanding (Diluted)	391.14M
Earnings per Share (EPS) (Basic)	$0.03
Earnings per Share (EPS) (Diluted)	$0.02
Balance Sheet Financials
Current Assets	$416.20M
Property, Plant, and Equipment	$161.58M
Long-Term Assets	$1.79B
Total Assets	$2.20B
Current Liabilities	$251.96M
Long-Term Debt	$265.93M
Long-Term Liabilities	$430.96M
Total Liabilities	$682.92M
Common Equity	$1.52B
Tangible Shareholders Equity	$50.00M
Shareholders Equity	$1.52B
Common Shares Outstanding	388.32M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$146.15M
Cash Flow from Investing Activities	$-36.12M
Cash Flow from Financial Activities	$-15.96M
Beginning Cash	$154.57M
End Cash	$248.64M
Increase/Decrease in Cash	$94.07M
Stock-Based Compensation	$74.70M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.65
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.15
Debt to Equity Ratio	0.17
Gross Margin	32.37%
Operating Margin	1.70%
EBIT Margin	1.70%
EBITDA Margin	5.61%
Pre-Tax Profit Margin	0.87%
Profit Margin	0.68%
Free Cash Flow	$110.03M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.65
Inventory Turnover	--
Receiveable Turnover	14.88
Days Sales in Receivables	24.53
Return on Equity	0.64%
Return on Tangible Equity	19.32%
Return on Assets	0.44%
Return on Investments	0.54%
Book Value Per Share	$3.92
Free Cash Flow per Share	$0.28
Operating Cash Flow per Share	$0.37

Data from Zacks Investment Research, Inc.